Stockscreener 앱 받기
15.94
1.48%
-0.24
전일 마감가:
$16.18
열려 있는:
$16.28
하루 거래량:
295.73K
Relative Volume:
0.58
시가총액:
$459.78M
수익:
$322.67M
순이익/손실:
$-61.63M
주가수익비율:
-8.1103
EPS:
-1.9654
순현금흐름:
$-124.21M
1주 성능:
-0.50%
1개월 성능:
+2.77%
6개월 성능:
-33.50%
1년 성능:
-11.05%
1일 변동 폭
$15.90
$16.47
1주일 범위
$15.88
$16.52
52주 변동 폭
$13.46
$31.04
Fulgent Genetics Inc Stock (FLGT) Company Profile
명칭
Fulgent Genetics Inc
전화
626-350-0537
주소
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
15.94 | 466.71M | 322.67M | -61.63M | -124.21M | -1.9654 |
TMO
Thermo Fisher Scientific Inc
|
524.57 | 195.48B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
194.54 | 138.36B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.01 | 46.31B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
122.09 | 34.18B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
335.23 | 32.95B | 3.17B | 642.63M | 516.49M | 10.77 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-05 | 업그레이드 | UBS | Neutral → Buy |
| 2023-12-07 | 개시 | UBS | Neutral |
| 2022-12-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | 개시 | Raymond James | Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-02-04 | 재개 | Piper Sandler | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Underperform |
| 2021-01-08 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-08-20 | 개시 | Oppenheimer | Outperform |
| 2020-05-29 | 개시 | BTIG Research | Buy |
| 2019-11-05 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
모두보기
Fulgent Genetics Inc 주식(FLGT)의 최신 뉴스
Fulgent Genetics Under Investigation for Securities Law Violations - Intellectia AI
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics - GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm - The Globe and Mail
Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026 - BioSpace
Stock Recap: Whats the analyst consensus on Fulgent Genetics Inc2026 Growth vs Value & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Pullback Watch: Is Fulgent Genetics Inc a momentum stock2026 Levels & Daily Momentum Trading Reports - baoquankhu1.vn
Stop Loss: Can Fulgent Genetics Inc stock outperform in a bear market2026 Biggest Moves & Risk Managed Investment Entry Signals - baoquankhu1.vn
Fulgent Genetics Inc (FLGT) Stock Down 3.9% -- Now Undervalued? GF Score: 64/100 - GuruFocus
Precision Trading with Fulgent Genetics Inc. (FLGT) Risk Zones - Stock Traders Daily
Buyback Watch: What is the long term forecast for Fulgent Genetics Inc stockEarnings Trend Report & Safe Entry Trade Signal Reports - baoquankhu1.vn
Can Fulgent Genetics Inc stock outperform in a bear marketTrade Risk Report & Long-Term Safe Investment Ideas - baoquankhu1.vn
Surprises Report: Can Fulgent Genetics Inc stock outperform in a bear market2026 Action & Accurate Buy Signal Alerts - baoquankhu1.vn
Hennion & Walsh Asset Management Inc. Makes New $1.74 Million Investment in Fulgent Genetics, Inc. $FLGT - MarketBeat
FULGENT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, ... - Bluefield Daily Telegraph
FULGENT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Dow Update: What are Fulgent Genetics Incs technical support levelsWeekly Stock Analysis & Risk Managed Investment Signals - baoquankhu1.vn
Aug Volume: What is the long term forecast for Fulgent Genetics Inc stockWeekly Loss Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
FLGT PE Ratio & Valuation, Is FLGT Overvalued - Intellectia AI
JPMorgan Chase & Co. Increases Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc - ACCESS Newswire
Fulgent Genetics (NASDAQ: FLGT) CEO cancels 750,000-share prepaid forward - Stock Titan
Fulgent Genetics (NASDAQ: FLGT) CEO reports 30.7% ownership stake - Stock Titan
[ARS] Fulgent Genetics, Inc. SEC Filing - Stock Titan
Fulgent Genetics (NASDAQ: FLGT) outlines 2026 meeting, pay and equity plan votes - Stock Titan
Fulgent Genetics (FLGT) price target decreased by 27.72% to 24.82 - MSN
Short Interest in Fulgent Genetics Rises 38.7% - National Today
Technical Reactions to FLGT Trends in Macro Strategies - Stock Traders Daily
Short Interest in Fulgent Genetics, Inc. (NASDAQ:FLGT) Rises By 38.7% - MarketBeat
Fulgent Genetics Receives 'Hold' Rating from Analysts - National Today
Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc. - lincolnjournal.com
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent ... - Bluefield Daily Telegraph
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022. - marketscreener.com
If You Invested $1,000 in Fulgent Genetics (FLGT) - Stock Titan
Aug Weekly: How is Fulgent Genetics Inc managing supply chain issues2026 Technical Patterns & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Fulgent Genetics, Inc.Common Stock (NQ: FLGT - The Chronicle-Journal
FLGT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - GlobeNewswire Inc.
Fulgent Genetics Completes $56.9M Acquisition of Bako Diagnostics and StrataDx to Expand Precision Medicine Services - Minichart
Trading the Move, Not the Narrative: (FLGT) Edition - Stock Traders Daily
Published on: 2026-03-19 03:58:12 - baoquankhu1.vn
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx - BioSpace
Fulgent Genetics completes $56.9M pathology lab acquisitions By Investing.com - Investing.com Australia
FULGENT GENETICS INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud - Business Wire
Fulgent Genetics Acquires Bako Diagnostics Assets, StrataDx for $56.9 Million - marketscreener.com
Fulgent Genetics completes $56.9M pathology lab acquisitions - Investing.com
Fulgent Genetics Expands Dermatology Footprint With Key Acquisitions - TipRanks
Fulgent Genetics (NASDAQ: FLGT) buys Bako Diagnostics and StrataDx - Stock Titan
Fulgent Genetics (NASDAQ:FLGT) Stock Price Crosses Below 50-Day Moving AverageHere's Why - MarketBeat
Fulgent Genetics (FLGT) Stock Analysis Report | Financials & Insights - Benzinga España
Fulgent Genetics seeks new collaborations at Copenhagen ADPD2026 event - Traders Union
Fulgent Genetics, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Fulgent Genetics Inc (FLGT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.57%
0.03%
자본화:
|
볼륨(24시간):